Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pyelonephritis acute, treatment

Warren JW, Abrutyn E, Hebei JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis. Clin Infect Dis 1999 29 745-758. [Pg.1158]

Levofloxacin (1), the levo-isomer or the (5)-enantiomer of ofloxacin, received FDA approval in 1996 (Fish, 2003 Hurst et al., 2002 Mascaretti, 2003 Norrby, 1999 North et al., 1998). The initial approval covered community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis, acute maxillary sinusitis, uncomplicated skin and skin structure infections, acute pyelonephritis, and complicated urinary tract infections (North et al., 1998). Four years later, the levofloxacin indication list grew to include community-acquired pneumonia caused by penicillin-resistant Streptococcus pneumoniae. In addition, in 2002, nosocomial (hospital-acquired) pneumonia caused by methicillin-susceptible Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Haemophilus influenzae, Kliebsella pneumoniae, and Escherichia coli was added (Hurst et al., 2002). Finally in 2004, LVX was approved as a post-exposure treatment for individuals exposed to Bacillus anthracis, the microbe that causes anthrax, via inhalation (FDA, 2004). [Pg.47]

Isepamicin is similar to amikacin but has better activity against strains that produce type I 6 -acetyltransferase. It can cause nephrotoxicity, vestibular toxicity, and ototoxicity. However, it is one of the less toxic of the aminoglycosides (1). The antibacterial spectrum of isepamicin includes Enterobacteriaceae and staphylococci anaerobes, Neisseriae, and streptococci are resistant (1). Isepamicin was as effective and safe as amikacin in the treatment of acute pyelonephritis in children and might prove an advantageous alternative in areas with a high incidence of resistance to other aminoglycosides (2). [Pg.1920]

Kafetzis DA, Maltezou HC, Mavrikou M, Siafas C, Paraskakis I, Delis D, Bartsokas C. Isepamicin versus amikacin for the treatment of acute pyelonephritis in children. Int J Antimicrob Agents 2000 14(l) 51-5. [Pg.1920]

In comparative trials involving commonly used regimens, levofloxacin had equivalent if not greater activity in the treatment of community-acquired pneumonia, acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis, acute pyelonephritis, and complicated urinary tract infection (5). [Pg.2048]

Cronberg S, Banke S, Bergman B, Boman H, Eilard T, Elbel E, Hugo-Persson M, Johansson E, Kuylenstierna N, Lanbeck P, Lindblom A, Paulsen O, Schonbeck C, Walder M, Wieslander P. Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefur-oxime. Scand J Infect Dis 2001 33(5) 339-43. [Pg.2584]

Davis GJ, McKenzie BE. Toxicologic evaluation of ofloxacin. The American journal of medicine. 1989 Dec 29 87(6C) 43S-6S. MoutonY, Ajana F,ChidiacC,CapronMH, Home P,Masquelier AM. A multicenter study of lomefloxacin and trimethoprim/sulfam-ethoxazole in the treatment of uncomplicated acute pyelonephritis.The American journal of medicine. 1992 Apr 6 92(4A) 87S-... [Pg.381]

Ertapenem is a carbapenem that inhibits cell wall synthesis. It is indicated in the treatment of moderate to severe complicated intra-abdominal infections, complicated skin and skin structure infections, community-acquired pneumonia, complicated urinary tract infections (UTIs) (including pyelonephritis), and acute pelvic infections (including postpartum endomyometritis, septic abortion. [Pg.238]

Loracarbef, a synthetic beta lactam antibiotic of the car-bacephem class (200 to 400 mg p.o. q. 12 hours), is used in the treatment of secondary bacterial infections of acute bronchitis, acute bacterial exacerbations or chronic bronchitis, of pneumonia, pharyngitis, tonsillitis, sinusitis, acute otitis media, uncomplicated skin and skin-structure infections, impetigo, uncomplicated cystitis, and in uncomplicated pyelonephritis. [Pg.397]

In an acute uncomplicated pyelonephritis, a 7-day course of oral fluoroquinolones (eg, ciprofloxacin) is a primary choice. Backup drugs, which may require a 14-day course of treatment, include amoxicillin-clavulanate, an oral cephalosporin (eg, cephalexin), or TMP-SMZ. [Pg.410]

Primary antibiotics used in hospitalized patients with acute pyelonephritis include intravenous fluoroquinolone, or ampicillin plus gentamicin, or a third-generation cephalosporin. Treatment is usually for 14 days. [Pg.410]

In another case, an elderly man treated with quinapril 20 mg daily for essential hypertension was found to have hyperkalaemia (serum potassium 7 to 7.4 mmol/L) and azotaemia after 20 days of treatment with co-tri-moxazole for mild acute pyelonephritis. Co-trimoxazole and quinapril were stopped, and nifedipine was given to control blood pressure. After treatment with dextrose, insulin, sodium polystyrene sulfonate and calcium gluconate, the azotaemia and hyperkalaemia resolved over 36 hours. ... [Pg.20]


See other pages where Pyelonephritis acute, treatment is mentioned: [Pg.1154]    [Pg.1706]    [Pg.1430]    [Pg.1431]    [Pg.293]    [Pg.359]    [Pg.417]    [Pg.307]    [Pg.303]    [Pg.359]   
See also in sourсe #XX -- [ Pg.328 ]




SEARCH



Pyelonephritis

Pyelonephritis treatment

© 2024 chempedia.info